Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Randomized Phase III Trial of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-Invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesEur Urol 2020 Aug 28;[EPub Ahead of Print], C Pfister, G Gravis, A Fléchon, M Soulié, L Guy, B Laguerre, N Mottet, F Joly, Y Allory, V Harter, S Culine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.